LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Phibro Animal Health Corp

Gesloten

SectorGezondheidszorg

54.6 2.86

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

52.82

Max

55.15

Belangrijke statistieken

By Trading Economics

Inkomsten

932K

27M

Verkoop

10M

374M

K/W

Sectorgemiddelde

22.797

108.767

EPS

0.87

Dividendrendement

0.91

Winstmarge

7.344

Werknemers

2,475

EBITDA

4.7M

67M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-8.98% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.91%

2.21%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

25 mrt 2026

Volgende Ex Dividend datum

4 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

390M

2.1B

Vorige openingsprijs

51.74

Vorige sluitingsprijs

54.6

Nieuwssentiment

By Acuity

17%

83%

19 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Phibro Animal Health Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 feb 2026, 22:04 UTC

Winsten

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 feb 2026, 23:55 UTC

Marktinformatie

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 feb 2026, 23:40 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 feb 2026, 23:37 UTC

Marktinformatie

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 feb 2026, 23:32 UTC

Winsten

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 feb 2026, 23:19 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb 2026, 23:18 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 feb 2026, 23:01 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 22:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

26 feb 2026, 22:43 UTC

Marktinformatie

RBA Hike In March Is Being Underpriced -- Market Talk

26 feb 2026, 22:33 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb 2026, 22:13 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 feb 2026, 21:59 UTC

Winsten

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 feb 2026, 21:58 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

26 feb 2026, 21:49 UTC

Winsten

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 feb 2026, 21:45 UTC

Winsten

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 feb 2026, 21:44 UTC

Winsten

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 feb 2026, 21:44 UTC

Winsten

Coles Expects Market to Remain Highly Competitive

26 feb 2026, 21:44 UTC

Winsten

Coles Says Supermarket Customers Remain Value Oriented

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 feb 2026, 21:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 feb 2026, 21:41 UTC

Winsten
Acquisities, Fusies, Overnames

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Peer Vergelijking

Prijswijziging

Phibro Animal Health Corp Prognose

Koersdoel

By TipRanks

-8.98% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 48.33 USD  -8.98%

Hoogste 58 USD

Laagste 38 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Phibro Animal Health Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

3 ratings

1

Buy

1

Hold

1

Sell

Technische score

By Trading Central

17 / N/ASteun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

19 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat